Getty Images Reportage photographer Daniel Berehulak was awarded the Pulitzer Prize today for his work covering the Ebola crisis in Liberia. Berehulak documented the outbreak as it spread through West Africa, capturing powerful and heart-wrenching images which showed the human face of a brutal disease. In a departure from traditional news coverage, he also created a series of portraits of the doctors, aid workers, and survivors who battled Ebola.

Berehulak told the New York Times, for whom he shot the work, “This award makes me think of all the people that shared their lives with me so that I was able to document this ghastly and horrible virus. It preys on our humanity — on everything that makes us human. People can’t hold their loved ones in their last dying moments because that’s when the virus is the most potent.”

Read More


A wedding dress designer has helped engineer a better Ebola suit
Fashion meets disease prevention.


The latest Ebola outbreak in West Africa has killed more than 10,000 people,including more than 200 healthcare workers. Although they wear protective clothing to try to keep themselves safe while treating infected patients, the current design has plenty of problems - not least of all the fact that it’s so hot it can only be worn for 45 minutes at a time. The hooded suit relies on separate goggles and leaves large patches of skin on the face exposed, giving the virus an opportunity to invade.

But now an unlikely team of engineers, students, public health workers and a wedding gown designer have teamed up to create a better prototype at Johns Hopkins University in the US. The team formed in response to a US Agency of International Development ‘Grand Challenge’ - call-outs that aim to get people from all over the world to work together to solve global problems.

“It was all consuming,” Jill Andrews, a Baltimore-based wedding dress designer, toldPBS News Hour. Andrews helped sew the new suit prototype, which is made out of a durable synthetic material called Tyvek. “It’s just about constantly solving problems and thinking about what needs to happen next.”

Their final design is now being refined further will begin production in the coming months before being shipped out to healthcare workers in Western Africa, and promises to be cooler, more comfortable and offer far better protection against Ebola.

Its primary benefit is the fact that there’s no exposed skin at all - the entire head is covered in a clear, plastic hood that has a ventilation channel that flows from top to bottom. This also means that it doesn’t fog up - something that happens as soon as you start wearing the goggles in current suits.

It can also be worn for 1.5 hours at a time rather than just 45 minutes, as the material is much lighter and cooler. And when you do want to take it off, the risk of contamination is far less as the zip is at the back of the suit, and you never have to touch it - you simple hook straps on the sleeves onto your shoes and stand up, pulling the while thing off.

The team came up with this design after using chocolate syrup to model how bodily fluids could spread and get onto the wearer’s skin.

“You rub the stuff all over yourself and then try to take off the suit and then see if any of it got on your skin,” Youseph Yazdi, from the Johns Hopkins University Centre for Bioengineering, Innovation and Design, told PBS. “It’s a poor man’s simulation.”

USAID believes this collaborative approach to problem solving is the way of the future, and they’re not the only ones - with organisations like the Gates Foundation putting out similar calls to action to attract thinkers from all walks of life to createbetter condoms and help improve water sanitation.

“The old approach of having people spend years in the lab developing stuff is great to develop new science and technology,” said Yazdi. “But when it comes to solving problems, to bridging between science … and human need, this approach is really, I think, a very good one to take.”

We couldn’t agree more. Bring it on.

Watch the full PBS report (source link has the video


A few months ago, the US acted like this was the end of the world. The epidemic isn’t over yet. Where’s the coverage?

Subscribe to The Breakfast Club!

(via https://www.youtube.com/watch?v=uUnZURCue1w)

Morning News Rundown

As city goes renewable, impact of biomass power raises questions

‘Release cards’ turn inmates and families into profit stream

Mysterious hanging deaths in the South recall painful history  

Opinion: Europe anticipates renewed hostilities in Ukraine

WHO admits failings in dealing with Ebola

Explosions rock Yemeni capital

EU meets on migrant crisis after boat tragedy

China unveils trade plan with Pakistan

Opinion: Xenophobia haunts ‘rainbow nation’

Baltimore probes man’s death after arrest

Opinion: Incentives compel teachers to cheat

Deadly attack targets UN staff in Somalia

Six arrested in ISIL-related inquiry 

US, Philippines to drill despite China row

FBI: Hair-match experts’ testimony flawed

Houthi leader vows to defy Saudi-led air war

A kitten plays at the feet of the Paramount Chief presiding over some 25,000 people in the Kenema district.

Image and text by Amy Maxmen, via Instagram. Sierra Leone, 2014. 

Read  ‘Sierra Leone: Blood from Ebola Survivors Shows Promise in a Clinical Trial’- Amy Maxmen, from the project, “Disaster Science During the Ebola Outbreak.”

24 April 2015

Banishing Ebola

The Ebola outbreak in West Africa is still ongoing, with over 24,000 recorded cases and no licensed treatment or vaccine. Understanding how the body interacts with – and attempts to fight – the virus is key to developing effective vaccines. B- and T-cells are the body’s defence against disease – when they find infection they will multiply and attack. Importantly, these immune cells will ‘remember’ the illness, creating immunity to re-infection. Until now it was believed that the Ebola virus (pictured) was an immunosuppressant, which limited the body’s ability to fight back in this way. But monitoring the response of B- and T-cells in four patients infected with Ebola showed that there was significant B- and T-cell activation, with particularly large proportions of CD8-type T cells. These T cells targeted specific proteins on the virus, suggesting that medicine containing these proteins will activate the production of CD8 T cells, providing effective future vaccination against Ebola.

Written by Helen Thomas

Image by Cynthia Goldsmith and Pierre Rollin
Centers for Disease Control and Prevention, USA
Originally published under a Creative Commons Licence (BY 4.0)
Research published in PNAS, April 2015

You can also follow BPoD on Twitter and Facebook

A woman wandered sluggishly into a village far from her home. The “headman” in charge called for an ambulance, suspecting Ebola. It was unclear whether she arrived by foot or motorcycle, so they sprayed the bike down with chlorine just in case.  

Image and text by Amy Maxmen, via Instagram. Sierra Leone, 2014.

Read more about Pulitzer Center grantee Amy Maxmen reporting from Sierra Leone about the Ebola virus here. 

UN chief names new head of Ebola mission as outbreak calms - SunHerald.com

UN chief names new head of Ebola mission as outbreak calms – SunHerald.com

MONROVIA, Liberia — The U.N. chief on Saturday appointed a new head of the emergency mission responding to West Africa’s Ebola crisis amid hopes that the world’s deadliest outbreak of the virus will soon come to an end. A statement from Ban Ki-moon’s …
Ebola outbreak likely driving malaria deaths – studyNews24

all 405 news articles

View On WordPress